Theriva Biologics, Inc. (TOVX) Misses Q3 EPS by 652c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($6.81), $6.52 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• Roblox announces standalone apps, browser play, and creator wallet
• BetterLife Pharma files final prospectus for $100M public offering